Brawn Biotech Limited

₹21.05As of Sun 8 Nov 2026, 12:00 UTC
BSE:530207Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR (9.64%)
Div yield —
ROE 19.86%
Pharmaceutical Preparations
Beta (5Y) 0.11
PE TTM 7.964
TSR TTM (0.24%)
Mkt cap ₹63.16M
ROIC (4.67%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹21
(0.83%)
(54.51%)
Hold 5|2|8|6|5
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.26
0.27
0.27
0.28
27.31%
23.46%
20.92%
12.54%
Revenue₹M
4.173
4.404
4.607
4.811
10.60%
15.95%
14.95%
18.72%
Peers (US$0.673M)
Cap (US$)
PE
0.630M
213.3x
Capital
TTM
5Y
10Y
Leveragex
2.179
0.974
0.756
EBIT/Intx
1.772
2.306
2.056
Own earn%
(165.40)
44.17
43.59
Sh yield%
35.33
49.26
51.06
Owners
Insiders/Inst%
4.16
53.64
Short interest%
2.80
SBC / revenue%
2.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
29–34
$1 testx
—
Incr. ROIC%
5